#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypersensitivity pneumonitis Usher's syndrome Desmoplastic small round cell tumour Primary myelofibrosis Mixed-type liposarcoma Basal cell naevus syndrome Necrotising myositis Mantle cell lymphoma recurrent Mantle cell lymphoma stage III Lennox-Gastaut syndrome Leiomyosarcoma recurrent Lip and/or oral cavity cancer Choroidal dystrophy Methylmalonic acidaemia Congenital growth hormone deficiency More trials…

    Learn about Rare Diseases

    Ocular melanoma – Basic Information Myelodysplastic syndrome – Basic Information Hepatoblastoma Crigler-Najjar syndrome – Basic Information Ornithine transcarbamoylase deficiency Methylmalonic acidaemia – Diagnostics Rosai-Dorfman syndrome Netherton’s syndrome – Life with Disease Mantle cell lymphoma stage II – Trials in Disease Rhabdoid tumour – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AMG 732 Orlistat Tiratricol DROSPIRENONE Mifepristone MB-CART2219.1 Tominersen Ipratropium Bromide Hydroxychloroquine Sulfate Pf-06480605 Zinc Oxide Ecoo16 12 Grass Pollen Mixture Remifentanil Hydrochloride Delafloxacin Protein C Cefaclor Feladilimab Hydrochlorothiazide Trimethoprim More therapies…

    Learn about Your Condition

    Pyoderma gangrenosum Leiomyosarcoma recurrent Chondrosarcoma metastatic Wolfram syndrome Crigler-Najjar syndrome Peritoneal dialysis Pelvic venous thrombosis Neoplasm malignant Schizophreniform disorder Neuralgia Latent tuberculosis Cerebral palsy Acute hepatic failure Mast cell activation syndrome Heart transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effects of (+)-α-Dihydrotetrabenazine for Patients with Moderate to Severe Tardive Dyskinesia

    Recruiting

    2 1
    Investigated Drugs:
    • (2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol
    Czechia Hungary Poland Slovakia

  • Study on the Effectiveness of Ozone Therapy for Pain Relief in Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy

    Recruiting

    4 1 1
    Investigated Diseases:
    • Neuropathy peripheral
    Investigated Drugs:
    • Oxygen
    Spain

  • Imaging Study with 89Zr-Bevacizumab for Predicting Treatment Effects in Patients with NF2-Related Schwannomatosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Investigated Drugs:
    • Bevacizumab Zirconium Zr-89
    The Netherlands

  • Study of individualized doses of botulinum toxin type A (incobotulinumtoxin) in adults with severe spasticity caused by brain damage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Spain

  • Study on the Safety and Effectiveness of Botulinum Toxin A for Patients with Persistent Post-Traumatic Headache

    Recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Chloride
    Denmark

  • Study on the Effects of Etidronate on Brain Calcification in Patients with Fahr’s Disease

    Recruiting

    2 1
    Investigated Drugs:
    • Etidronate Disodium
    The Netherlands
Previous Page
1 … 34 35 36 37 38 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!